23:00:46 Europe / Stockholm
2024-04-08 09:16:00

Abliva's CMO Magnus Hansson attended the 8[th] annual meeting of Mitochondrial Medicine - Therapeutic Development in March. The conference brings together leaders in translational mitochondrial medicine to discuss recent advances in the area of mitochondrial research and clinical development. BioStock spoke with Hansson to better understand how scientific meetings like this one fit into the company's overall mission

Read the article at biostock.se:

Abliva's mission to become mitochondrial medicine powerhouse - BioStock (https://www.biostock.se/en/?p=50876&preview=true)
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/